Codex DNA Q1 EPS $(0.45), Inline, Sales $5.60M Beat $3.90M Estimate

Codex DNA (NASDAQ:DNAY) reported quarterly losses of $(0.45) per share which met the analyst consensus estimate. This is a 68.53 percent increase over losses of $(1.43) per share from the same period last year. The company reported quarterly sales of $5.60 million which beat the analyst consensus estimate of $3.90 million by 43.59 percent. This is a 143.48 percent increase over sales of $2.30 million the same period last year.